arginine has been researched along with aurintricarboxylic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Kawamoto, S; Tatibana, M | 1 |
Atkinson, EA; Bleackley, RC; Helgason, CD; Pinkoski, MJ | 1 |
Abend, M; Frombeck, S; Van Beuningen, D | 1 |
4 other study(ies) available for arginine and aurintricarboxylic acid
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Arginine activation of N-acetylglutamate synthetase in mouse liver. Enhancement of the sensitivity in vivo by parenteral treatment with inhibitors of nucleic acid and protein synthesis.
Topics: Acetyltransferases; Amino Acids; Amino-Acid N-Acetyltransferase; Animals; Arginine; Aurintricarboxylic Acid; Cycloheximide; Dose-Response Relationship, Drug; Emetine; Enzyme Activation; Liver; Mice; Nucleic Acids; Protein Biosynthesis; Puromycin | 1983 |
Proteinases are involved in both DNA fragmentation and membrane damage during CTL-mediated target cell killing.
Topics: Animals; Arginine; Aurintricarboxylic Acid; Cells, Cultured; Coumarins; Cytotoxicity, Immunologic; DNA; Endopeptidases; Isocoumarins; Kinetics; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Protease Inhibitors; Substrate Specificity; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Tyrosine | 1995 |
Indications for an active process underlying spontaneous and radiation-induced micronucleation in L929 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aurintricarboxylic Acid; Benzhydryl Compounds; Bromodeoxyuridine; Cell Division; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; DNA, Neoplasm; Electrophoresis, Gel, Pulsed-Field; Endonucleases; Enzyme Inhibitors; Fibrosarcoma; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Proliferating Cell Nuclear Antigen; Protein Kinase C; Spermine; Sphingosine; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 1999 |